Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WEGO Terumo is a joint venture established between the Chinese medical technology leader WEGO Group and the Japanese global medical corporation Terumo. Founded in 2010 and based in Weihai, China, the company focuses on the production and distribution of peritoneal dialysis (PD) products. Its primary offerings include advanced peritoneal dialysis solutions and the associated medical hardware required for treatment. By combining Terumo's technological expertise in nephrology with WEGO's robust manufacturing and market presence in China, the company serves a critical role in treating patients with end-stage renal disease. The joint venture operates high-standard manufacturing facilities to meet the growing demand for dialysis therapies in the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WEGO Terumo.